EPO Patents = 3

Forward Citations = 349

Loading Chart...

6 inventors (with patents filed for the assignee):

Takefumi Gemba (4 out of 9 patents)

Takeshi Wada (3 out of 67 patents)

Ryoichi Nagata (3 out of 17 patents)

4. Mamoru Shimizu (3 out of 12 patents)

5. Yusuke Torikai (1 out of 1 patent)

6. Ikumi Shiga (1 out of 1 patent)

7. Wada Takeshi (0 patent)

8. Arai Kouichiro (0 patent)

9. Shimizu Mamoru (0 patent)

7 patents: Sort by Forward Citations

1. 10322173 - Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent (2019-06-18),

2. 10149905 - Chiral nucleic acid adjuvant having antitumor effect and antitumor agent (2018-12-11),

3. 10144933 - Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator (2018-12-04),

4. 9695211 - Method for the synthesis of phosphorus atom modified nucleic acids (2017-07-04),

5. 9617547 - Chiral nucleic acid adjuvant (2017-04-11),

6. 9598458 - Asymmetric auxiliary group (2017-03-21),

7. 9394333 - Method for the synthesis of phosphorus atom modified nucleic acids (2016-07-19),

Wave Life Sciences Japan, Inc. is a biotechnology company focused on designing, developing, and commercializing nucleic acid therapeutics for patients with serious, genetically defined diseases. The company's innovative approach to drug development aims to address the root cause of genetic disorders through precision medicine. With a strong commitment to scientific excellence and patient-centric innovation, Wave Life Sciences Japan, Inc. is dedicated to improving the lives of patients and their families.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

7 Patents

#7 in Kagoshima

#5,441 in Japan

Kagoshima, Japan

Wave Life Sciences Japan, Inc.